Cynosure is a biotechnology and manufacturing company founded in 1991, specializing in the development and manufacturing of light-based aesthetic and medical treatment systems. These products cater to a wide range of treatment applications, including hair removal, skin rejuvenation, scar reduction, and the treatment of vascular lesions. Clayton Dubilier & Rice recently led a $60.00M private equity round investment in Cynosure on 17 May 2022, showcasing confidence from prominent investors in the company's potential for growth and innovation.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | $60.00M | 1 |
|
17 May 2022 |
No recent news or press coverage available for Cynosure, LLC..
We care about your data, and we'd love to use cookies make your experience better.
